These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8807048)

  • 1. New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
    Flattery AM; Abruzzo GK; Gill CJ; Smith JG; Bartizal K
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1604-9. PubMed ID: 8807048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
    Martinez-Suarez JV; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 1996 May; 40(5):1277-9. PubMed ID: 8723483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
    Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K
    J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
    Samonis G; Maraki S; Hajiioannou I; Chatzinikolaou I; Rolston KV; Bodey GP; Kontoyiannis DP
    J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.
    Abruzzo GK; Flattery AM; Gill CJ; Kong L; Smith JG; Krupa D; Pikounis VB; Kropp H; Bartizal K
    Antimicrob Agents Chemother; 1995 May; 39(5):1077-81. PubMed ID: 7625792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
    J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans gastrointestinal colonization and invasion in the mouse: effect of antibacterial dosing, antifungal therapy and immunosuppression.
    Kinsman OS; Pitblado K
    Mycoses; 1989 Dec; 32(12):664-74. PubMed ID: 2695843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Ellepola AN; Samaranayake LP
    Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
    Kiraz N; Anğ O; Akgün Y; Erturan Z
    Mycoses; 2000; 43(3-4):119-23. PubMed ID: 10907341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    Arch Oral Biol; 1998 Dec; 43(12):999-1007. PubMed ID: 9877331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evidences for a role of subinhibitory concentrations of rilopirox, nystatin and fluconazole on adherence of Candida spp. to vaginal epithelial cells.
    Braga PC; Maci S; Dal Sasso M; Bohn M
    Chemotherapy; 1996; 42(4):259-65. PubMed ID: 8804793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.
    Bartizal K; Scott T; Abruzzo GK; Gill CJ; Pacholok C; Lynch L; Kropp H
    Antimicrob Agents Chemother; 1995 May; 39(5):1070-6. PubMed ID: 7625791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anti-Candida activity and toxicology of LY121019.
    Gordee RS; Zeckner DJ; Ellis LF; Thakkar AL; Howard LC
    J Antibiot (Tokyo); 1984 Sep; 37(9):1054-65. PubMed ID: 6389460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 May; 27(5):213-9. PubMed ID: 9682984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.